Building precision therapeutic platforms that create measurable value for every stakeholder — from the clinician at the bedside to the patient in recovery, the payer managing cost, and the caregiver providing continuity of care.
Transformative delivery platforms for peptides
Vector Science & Therapeutics is building precision therapeutic platforms that matter to every stakeholder in the care continuum. Physicians gain a site-directed tool that performs where systemic therapy cannot. We believe our delivery platforms are transformative and will become the standard of care for peptides and other regenerative therapeutics. Clinicians gain confidence in durable, localized delivery. Patients gain recovery with fewer systemic trade-offs. Payers gain interventions designed to reduce downstream burden. Caregivers gain therapies that work across the full arc of patient care. We invite investors and institutional partners to join us in building platforms with that reach.
Targeted post-surgical and injury recovery applications where site-directed, non-opioid intervention can dramatically reduce recovery time and systemic drug burden.
Long-term musculoskeletal conditions including osteoarthritis and chronic pain disorders — markets where sustained, localized therapy offers a compelling alternative to systemic medications.
Alongside VectorMist™, Vector is building a dedicated cGMP peptide manufacturing and quality-testing capability to supply orthopedic, sports medicine, and regenerative medicine channels through qualified third-party distributors.
Vector Science & Therapeutics Corp. is publicly listed on the TSX Venture Exchange, trading under the symbol TSXV: PAIN.
For the latest corporate updates and milestones, please see our News page or reach out to investor relations directly.
Inaugural Quarterly Investor Q&A — Call Recording
July 28, 2026 · Video
Computershare Investor Services Inc.
Phone
1-800-564-6253
(toll free — Canada & US)
514-982-7555
(international)
8:30 am – 8:00 pm Eastern Time
Fax
1-888-453-0330